与非传染性肺部并发症相关的常见可变免疫缺陷及其治疗:超越免疫球蛋白疗法
Austin J Parsons1, Domingo Franco-Palacios2, Bryan Kelly2
1Department of Internal Medicine Henry Ford Hospital Detroit Michigan USA.
Pulmonary circulation
|January 2, 2025
概括
常见的可变免疫缺陷 (CVID) 非传染性并发症可以严重影响多个器官,包括肺和肝脏. 尽管有先进的治疗方法,但这些疾病往往会进展,因此需要考虑器官移植.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 胃肠病学 胃肠病学
背景情况:
- 常见变性免疫缺陷 (CVID) 是一种主要免疫缺陷,其特点是低血糖球蛋白血症,疫苗反应不佳和复发性感染.
- 冠状病毒感染还可以表现为影响各种器官的非传染性系统性并发症.
- 了解这些非传染性方面对于全面的患者管理至关重要.
研究的目的:
- 在一组患者中描述CVID的非传染性并发症.
- 评估患有严重非传染性CVID症状的患者的临床过程和治疗反应.
- 突出潜在的需要先进的干预措施,如器官移植.
主要方法:
- 进行了一项单中心,回顾性,观察性研究.
- 根据欧洲免疫缺陷学会的标准,包括5名被诊断患有CVID的患者.
- 分析了临床表现,肺部和肝脏表现,治疗和结果的数据.
主要成果:
- 患者出现了各种肺部问题,包括肺炎,支气管切除症,粒状肺病和肺高血压.
- 三名患者表现出异常性血小板缺血症和非肝硬化门高血压,可能有结节性再生性增大.
- 尽管接受了肺血管扩张剂和免疫抑制治疗,但患者的疾病进展,导致器官移植评估.
结论:
- 冠状病毒感染的非传染性并发症显著影响多个器官系统,尽管目前的治疗方法,但可以进展.
- 在CVID中,先进的器官参与可能对医疗管理不耐药.
- 器官移植是CVID患者末期器官疾病的可行的治疗选择.
相关概念视频
Immunodeficiency Diseases
898
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
898
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139


